ATRA Message Board Post 9269114 | Atara Biotherapeutics...
home / stock / atra / atra message board
mariebell
(investorshub)
Posted on: Dec/21/2015 19:43:50
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=119326314
Need this to drop 10%
News, Short Squeeze, Breakout and More Instantly...
Atara Biotherapeutics Inc. Company Name:
ATRA Stock Symbol:
Market:
Atara Biotherapeutics Inc. Website:
-
ATA3219 Demonstrates Complete CD19-Specific B-Cell Depletion Against Systemic Lupus Erythematosus and Multiple Sclerosis Patient Peripheral Blood Mononuclear Cells ATA3219 Induces Lower Levels of Pro-Inflammatory Cytokines While Maintaining Cytotoxic Potency Compared With Autologous Bench...
-
First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration If Approved, Tab-cel Would be First Approved Therapy in U.S. for EBV+ PTLD Acceptance of BLA Will Trigger $20 Million Milestone Payment from Pierre Fabre Laboratories, with Potential for Additional...
- ATRA - Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
Tab-cel ® U.S. BLA on Track for Submission in Q2 2024 Initiation of ATA3219 Lupus Nephritis Study Expected in Q4 2024, with Initial Clinical Data Expected in H1 2025 Initiation of New ATA3219 Cohort Without Lymphodepletion in Severe Systemic Lupus Erythematosus Planned fo...